ASBrS Symposium 2024 | April 12 7:30-9:30 PM

Integrating genetic testing insights to optimize surgical decision making and personalize high-risk management

This session will educate the audience on how to incorporate genetic and genomic testing insights into clinical practice in order to guide personalized and preventative care and optimize surgical decision making for patients.

ASBrS Symposium 2024

Speakers:

Dr. David Weintritt, MD, FACS

Breast Cancer Surgeon at Virginia Cancer Specialists

Laura Brzeskiewicz, MS, CGC

Manager, Medical Science Liaisons at Myriad Genetics

Join us for this program by filling out the form below

April 12, 2024

7:30-9:30PM

Integrating genetic testing insights to optimize surgical decision-making and personalize high-risk management

Sorry, this form is not available.